A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
Titel:
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
Auteur:
Candelaria, M. Gallardo-Rincón, D. Arce, C. Cetina, L. Aguilar-Ponce, J.L. Arrieta, Ó González-Fierro, A. Chávez-Blanco, A. de la Cruz-Hernández, E. Camargo, M.F. Trejo-Becerril, C. Pérez-Cárdenas, E. Pérez-Plasencia, C. Taja-Chayeb, L. Wegman-Ostrosky, T. Revilla-Vazquez, A. Dueñas-González, A.